Business Description
Ligand Pharmaceuticals is a Florida-based biopharmaceutical company founded in 1987 that builds revenue by licensing a broad portfolio of drug assets to partners around the world rather than selling medicines directly to patients. Its portfolio spans a wide range of medical needs, including cancer, infectious disease, bone health, diabetes, and rare conditions, with partner products already approved and generating royalties alongside a pipeline of drugs still in development. This business model allows Ligand to earn income from multiple revenue streams while sharing the costs and risks of bringing new treatments to market.
